(Q46982754)

27 December 2017

editorial

0 references

title

Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom (English)

1 reference

27 December 2017

primary biliary cholangitis

main subject

0 references

author name string

Christophe Corpechot

series ordinal

1

1 reference

27 December 2017

Raoul Poupon

series ordinal

2

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

27 December 2017

published in

Hepatology

1 reference

27 December 2017

volume

46

1 reference

27 December 2017

issue

4

1 reference

27 December 2017

page(s)

963-965

1 reference

27 December 2017

Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study.

cites work

1 reference

7 January 2021

The UK General Practice Research Database

1 reference

7 January 2021

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

1 reference

7 January 2021

Primary biliary cirrhosis

1 reference

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

7 January 2021

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

7 January 2021

Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials

1 reference

7 January 2021

Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses

1 reference

7 January 2021

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

7 January 2021

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis

1 reference

7 January 2021

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

7 January 2021

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

1 reference

7 January 2021

Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment

1 reference

7 January 2021

Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.

1 reference

7 January 2021

Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients

1 reference

7 January 2021

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

1 reference

7 January 2021

Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center

1 reference

7 January 2021

Primary biliary cirrhosis once rare, now common in the United Kingdom?

1 reference

7 January 2021

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

7 January 2021

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21871

1 reference

27 December 2017

1 reference

27 December 2017